Accession Therapeutics
Oxford
About Accession Therapeutics
Accession Therapeutics is developing novel immuno-oncology therapeutics – combining high specificity and potency to counter tumor diversity. It is the first company to have engineered a viral point of entry to cancer cells while bypassing healthy cells - so it’s ‘gloves off’ in the fight against cancer." It was founded in 2020 and is located in Oxford, Oxfordshire, United Kingdom.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $106.6M
- Last round: Undisclosed (Dec 2025)
- Website: accessiontherapeutics.com
- Phone: +44-1865-950220
Industries & Categories
Biopharma, Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/accession-therapeutics-30565 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.